Guobang Pharma Ltd. (605507.SH) plans to repurchase shares worth 100 million to 200 million yuan.

10/03/2025

GMT Eight

Guobang Pharma Ltd.(605507.SH) announced that the company plans to repurchase shares worth 100 million to 200 million yuan, with a repurchase price not exceeding 25 yuan per share. The repurchased shares will be used for employee shareholding plans or stock incentives.

Swire Pacific A (00019) spent approximately HK$1.7429 million to repurchase 25,000 shares on March 10th.

ZERO FINTECH (00093) releases good news that it is expected to increase its annual profit before tax by at least approximately HK$30 million compared to the previous year.

Contact: contact@gmteight.com

Guobang Pharma Ltd. (605507.SH) plans to repurchase shares worth 100 million to 200 million yuan.

RECOMMEND

US Stock Market Move | Mineralys Therapeutics (MLYS.US) surges over 53% with the positive results of the release of hypertension drug research.

US Stock Market Move | Bitcoin fell below the $80,000 threshold and concept stocks plummeted across the board.

US Stock Market Move | In February, the combined revenue decreased by 11.3% month-on-month. Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) dropped more than 4%.